7 states to get Zydus Cadila's Covid vax ZyCoV-D

Zydus Cadila's COVID-19 vaccine ZyCoV-D will initially be used in seven states, including Maharashtra, Tamil Nadu, Uttar Pradesh and West Bengal, which have been recommended to identify the......

Zydus Cadila reduces price of its vax for those above 12 yrs

Zydus Cadila has agreed to bring down the price of its COVID-19 vaccine to Rs 265 a dose following persistent negotiations by the government but a final deal is yet to be reached, sources said on......

Zydus Cadila proposes Rs 1,900 for 3 jabs of DNA-based vaccine

With talks underway between the central government and Zydus Cadila over the pricing of the COVID-19 vaccine ZyCov-D, the pharma company is learnt to have proposed a price of Rs 1,900 for its......

Zydus Cadila to begin vaccine trials for kids above 5 yrs soon

So far, no other vaccine has been approved globally for children below 12 years.Sohini Das reports.  IMAGE: A beneficiary receives a dose of the Covid-19 vaccine at a vaccination centre in......

Cadila Pharma to enter skin care segment

The Ahmedabad-based Rs 550 crore (Rs 5.5 billion) Cadila Pharmaceuticals Lid has introduced its first skincare product, 'Umrela,' on Tuesday. The new launch is part if its strategy to enter the Rs......

Clinical trial deaths rise; pharma cos say not at fault

Despite courts slamming the authorities over the monitoring of clinical trials in the country, the number of deaths caused by the adverse impact of drugs in these processes has risen. Data from......

Pharma emerges as major recruiter

With traditional sectors like banking and finance taking a backseat at most B-school placements, sectors like pharmaceutical and healthcare have emerged as major recruiters. Firms like Abbot,......

Local pharma players storm MNC bastion

Domestic pharmaceutical companies are going global with direct presence in multi-locations in the world. The number of local pharma multinationals has gone up to 12 in 2004-05 and 2005-06 owing to......